Sandro Wagner

Sandro Wagner is a researcher in the Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology, and Oncologic Center. His work focuses on oncology, hematology, and molecular biology with a particular emphasis on head and neck cancers, B-cell lymphomas, and clonal evolution in malignant diseases. He has contributed to studies analyzing checkpoint inhibitor therapies, chemoradiotherapy efficacy, and genetic heterogeneity in tumors. His research often involves collaborations with institutions like the Austrian Head and Neck Cancer Registry.

Key research interests include immunotherapy applications in head and neck cancers, genetic mechanisms underlying lymphoma recurrence, and spatial heterogeneity in tumor biology. His publications highlight advancements in understanding treatment outcomes and molecular markers predictive of clinical success.